vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and Nasdaq, Inc. (NDAQ). Click either name above to swap in a different company.

Nasdaq, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.8× ILLUMINA, INC.). ILLUMINA, INC. runs the higher net margin — 28.8% vs 24.3%, a 4.5% gap on every dollar of revenue. On growth, ILLUMINA, INC. posted the faster year-over-year revenue change (5.0% vs 2.0%). Over the past eight quarters, Nasdaq, Inc.'s revenue compounded faster (9.2% CAGR vs -0.7%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Nasdaq Stock Market is an American stock exchange, the second-largest by market cap on the list of stock exchanges, and the first fully electronic stock market. The exchange is based in Manhattan, New York City, and is among the most active stock trading venue by volume in the United States.

ILMN vs NDAQ — Head-to-Head

Bigger by revenue
NDAQ
NDAQ
1.8× larger
NDAQ
$2.1B
$1.2B
ILMN
Growing faster (revenue YoY)
ILMN
ILMN
+3.0% gap
ILMN
5.0%
2.0%
NDAQ
Higher net margin
ILMN
ILMN
4.5% more per $
ILMN
28.8%
24.3%
NDAQ
Faster 2-yr revenue CAGR
NDAQ
NDAQ
Annualised
NDAQ
9.2%
-0.7%
ILMN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ILMN
ILMN
NDAQ
NDAQ
Revenue
$1.2B
$2.1B
Net Profit
$334.0M
$519.0M
Gross Margin
65.5%
Operating Margin
17.4%
30.7%
Net Margin
28.8%
24.3%
Revenue YoY
5.0%
2.0%
Net Profit YoY
185.5%
31.4%
EPS (diluted)
$2.16
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$2.1B
Q4 25
$1.2B
$2.1B
Q3 25
$2.0B
Q2 25
$2.1B
Q1 25
$2.1B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$1.9B
Q2 24
$1.1B
$1.8B
Net Profit
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$519.0M
Q4 25
$334.0M
$518.0M
Q3 25
$423.0M
Q2 25
$452.0M
Q1 25
$395.0M
Q4 24
$186.0M
$355.0M
Q3 24
$705.0M
$306.0M
Q2 24
$-2.0B
$222.0M
Gross Margin
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
65.5%
65.5%
Q3 25
67.2%
Q2 25
62.5%
Q1 25
59.2%
Q4 24
65.9%
60.4%
Q3 24
69.0%
60.3%
Q2 24
64.8%
64.7%
Operating Margin
ILMN
ILMN
NDAQ
NDAQ
Q1 26
30.7%
Q4 25
17.4%
29.7%
Q3 25
29.9%
Q2 25
27.2%
Q1 25
26.2%
Q4 24
15.8%
25.4%
Q3 24
68.6%
23.6%
Q2 24
-147.2%
23.6%
Net Margin
ILMN
ILMN
NDAQ
NDAQ
Q1 26
24.3%
Q4 25
28.8%
24.4%
Q3 25
21.6%
Q2 25
21.6%
Q1 25
18.9%
Q4 24
16.8%
17.5%
Q3 24
65.3%
16.1%
Q2 24
-178.8%
12.4%
EPS (diluted)
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$0.91
Q4 25
$2.16
$0.90
Q3 25
$0.73
Q2 25
$0.78
Q1 25
$0.68
Q4 24
$1.16
$0.62
Q3 24
$4.42
$0.53
Q2 24
$-12.48
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
NDAQ
NDAQ
Cash + ST InvestmentsLiquidity on hand
$1.6B
$515.0M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$2.7B
$12.0B
Total Assets
$6.6B
$27.3B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$515.0M
Q4 25
$1.6B
$604.0M
Q3 25
$470.0M
Q2 25
$732.0M
Q1 25
$690.0M
Q4 24
$93.0M
$592.0M
Q3 24
$70.0M
$266.0M
Q2 24
$74.0M
$416.0M
Total Debt
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$9.0B
Q4 25
$8.6B
Q3 25
$8.7B
Q2 25
$8.7B
Q1 25
$8.9B
Q4 24
$9.1B
Q3 24
$9.4B
Q2 24
$9.2B
Stockholders' Equity
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$12.0B
Q4 25
$2.7B
$12.2B
Q3 25
$12.0B
Q2 25
$11.8B
Q1 25
$11.5B
Q4 24
$2.4B
$11.2B
Q3 24
$2.1B
$11.1B
Q2 24
$1.4B
$10.9B
Total Assets
ILMN
ILMN
NDAQ
NDAQ
Q1 26
$27.3B
Q4 25
$6.6B
$31.1B
Q3 25
$30.7B
Q2 25
$30.4B
Q1 25
$30.6B
Q4 24
$6.3B
$30.4B
Q3 24
$6.0B
$30.6B
Q2 24
$6.1B
$30.2B
Debt / Equity
ILMN
ILMN
NDAQ
NDAQ
Q1 26
0.74×
Q4 25
0.70×
Q3 25
0.72×
Q2 25
0.73×
Q1 25
0.77×
Q4 24
0.81×
Q3 24
0.85×
Q2 24
0.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
NDAQ
NDAQ
Operating Cash FlowLast quarter
$321.0M
Free Cash FlowOCF − Capex
$267.0M
FCF MarginFCF / Revenue
23.0%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.96×
TTM Free Cash FlowTrailing 4 quarters
$935.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
$321.0M
$625.0M
Q3 25
$221.0M
Q2 25
$746.0M
Q1 25
$663.0M
Q4 24
$364.0M
$705.0M
Q3 24
$316.0M
$244.0M
Q2 24
$80.0M
$460.0M
Free Cash Flow
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
$267.0M
$536.0M
Q3 25
$152.0M
Q2 25
$687.0M
Q1 25
$614.0M
Q4 24
$335.0M
$645.0M
Q3 24
$284.0M
$188.0M
Q2 24
$49.0M
$408.0M
FCF Margin
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
23.0%
25.2%
Q3 25
7.8%
Q2 25
32.9%
Q1 25
29.4%
Q4 24
30.3%
31.7%
Q3 24
26.3%
9.9%
Q2 24
4.4%
22.8%
Capex Intensity
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
4.2%
Q3 25
3.5%
Q2 25
2.8%
Q1 25
2.3%
Q4 24
2.6%
3.0%
Q3 24
3.0%
2.9%
Q2 24
2.8%
2.9%
Cash Conversion
ILMN
ILMN
NDAQ
NDAQ
Q1 26
Q4 25
0.96×
1.21×
Q3 25
0.52×
Q2 25
1.65×
Q1 25
1.68×
Q4 24
1.96×
1.99×
Q3 24
0.45×
0.80×
Q2 24
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$990.0M85%
Service and other revenue$169.0M15%

NDAQ
NDAQ

Market Services$1.0B49%
Capital Access Platforms$565.0M26%
Financial Technology$517.0M24%
Other Revenues$8.0M0%

Related Comparisons